• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人自然杀伤细胞对乳腺癌细胞系扩增与激活的优化

Optimization of Expansion and Activation of Human Natural Killer Cells against Breast Cancer Cell Line.

作者信息

Peighambarzadeh Farzaneh, Najafalizadeh Anahita, Esmaeil Nafiseh, Rezaei Abbas, Ashrafi Farzaneh, Ganjalikhani Hakemi Mazdak

机构信息

Department of Immunology, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.

Hematology Division, Department of Internal Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.

出版信息

Avicenna J Med Biotechnol. 2020 Jan-Mar;12(1):17-23.

PMID:32153734
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7035457/
Abstract

BACKGROUND

Regarding to the increase of cancer deaths in recent years and disability of common therapies to eradicate cancers, as well as expansion of Natural Killer (NK) cell therapy, it seems so vital to find new useful therapies against cancers. Breast cancer is the second main cause of cancer death among women. As it is impossible for a majority of patients to receive NK cell therapy, an attempt was made to establish a low-cost and efficient method for expanding and activating NK cells against breast cancer cell line (MCF7).

METHODS

NK cells were isolated from Peripheral Blood Mononuclear Cells (PBMCs) applying either MACS based NK cell enrichment kit or antibodies and complement as cytotoxic method. Then, the NK cells were cultured in Stem Cell Growth Medium (SCGM) with feeder layer (irradiated PBMCs) along with PHA or OKT3. IL-2, IL-15 and IL-21 were used to expand NK cells and finally their cytotoxic activity was investigated by flow cytometry.

RESULTS

Highly pure NK cells were obtained and no significant difference between the two isolation methods was found. Using IL-2 plus IL-15, the number of NK cells increased up to100 fold after 16 days. No significant effect was observed after IL-21 treatment.

CONCLUSION

Our data indicated that cytotoxicity method can be considered a low-cost alternative for NK cell isolation kits. It seems that culturing NK cells for 14 days in either PHA or OKT3 supplemented SCGM medium would be more effective than culturing for 16 days in the presence of IL-21.

摘要

背景

鉴于近年来癌症死亡人数的增加以及常规疗法在根除癌症方面的不足,同时随着自然杀伤(NK)细胞疗法的发展,寻找新的有效抗癌疗法显得至关重要。乳腺癌是女性癌症死亡的第二大主要原因。由于大多数患者无法接受NK细胞疗法,因此尝试建立一种低成本且高效的方法来扩增和激活针对乳腺癌细胞系(MCF7)的NK细胞。

方法

使用基于磁珠分选的NK细胞富集试剂盒或抗体及补体作为细胞毒性方法,从外周血单个核细胞(PBMCs)中分离NK细胞。然后,将NK细胞在含有饲养层(经辐照的PBMCs)的干细胞生长培养基(SCGM)中与PHA或OKT3一起培养。使用IL-2、IL-15和IL-21来扩增NK细胞,最后通过流式细胞术研究其细胞毒性活性。

结果

获得了高纯度的NK细胞,两种分离方法之间未发现显著差异。使用IL-2加IL-15,16天后NK细胞数量增加了100倍。IL-21处理后未观察到显著效果。

结论

我们的数据表明,细胞毒性方法可被视为NK细胞分离试剂盒的低成本替代方法。在添加PHA或OKT3的SCGM培养基中培养NK细胞14天似乎比在IL-21存在下培养16天更有效。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f85/7035457/8a11d2c87023/AJMB-12-17-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f85/7035457/989f1f0c3400/AJMB-12-17-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f85/7035457/d98a2e370668/AJMB-12-17-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f85/7035457/bdf4b13e9a31/AJMB-12-17-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f85/7035457/8a11d2c87023/AJMB-12-17-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f85/7035457/989f1f0c3400/AJMB-12-17-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f85/7035457/d98a2e370668/AJMB-12-17-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f85/7035457/bdf4b13e9a31/AJMB-12-17-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f85/7035457/8a11d2c87023/AJMB-12-17-g004.jpg

相似文献

1
Optimization of Expansion and Activation of Human Natural Killer Cells against Breast Cancer Cell Line.人自然杀伤细胞对乳腺癌细胞系扩增与激活的优化
Avicenna J Med Biotechnol. 2020 Jan-Mar;12(1):17-23.
2
The Synergistic Use of IL-15 and IL-21 for the Generation of NK Cells From CD3/CD19-Depleted Grafts Improves Their Expansion and Cytotoxic Potential Against Neuroblastoma: Perspective for Optimized Immunotherapy Post Haploidentical Stem Cell Transplantation.IL-15 和 IL-21 的协同作用可从 CD3/CD19 depleted 移植物中生成 NK 细胞,从而增强其扩增和对神经母细胞瘤的细胞毒性潜力:对单倍体造血干细胞移植后优化免疫治疗的展望。
Front Immunol. 2019 Dec 3;10:2816. doi: 10.3389/fimmu.2019.02816. eCollection 2019.
3
[Method for expansion in vitro of CD3-CD56+CD16+NK cells highly purified from human peripheral blood].[从人外周血中高度纯化的CD3-CD56+CD16+自然杀伤细胞的体外扩增方法]
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2010 Oct;18(5):1310-5.
4
Optimization of Human NK Cell Manufacturing: Fully Automated Separation, Improved Ex Vivo Expansion Using IL-21 with Autologous Feeder Cells, and Generation of Anti-CD123-CAR-Expressing Effector Cells.人自然杀伤细胞制备的优化:全自动分离,使用 IL-21 和自体饲养细胞进行体外扩增的改进,以及生成表达抗 CD123-CAR 的效应细胞。
Hum Gene Ther. 2017 Oct;28(10):897-913. doi: 10.1089/hum.2017.157. Epub 2017 Aug 15.
5
Umbilical cord mesenchymal stem cells increase expansion of cord blood natural killer cells.脐带间充质干细胞可增加脐血自然杀伤细胞的扩增。
Biol Blood Marrow Transplant. 2008 Sep;14(9):1031-1038. doi: 10.1016/j.bbmt.2008.06.016.
6
IL-27 enhances IL-15/IL-18-mediated activation of human natural killer cells.IL-27 增强了 IL-15/IL-18 介导的人自然杀伤细胞的激活。
J Immunother Cancer. 2019 Jul 5;7(1):168. doi: 10.1186/s40425-019-0652-7.
7
Natural Killer Cell Expansion with Autologous Feeder Layer and Anti-CD3 Antibody for Immune Cell Therapy of Hepatocellular Carcinoma.利用自体饲养层和抗CD3抗体扩增自然杀伤细胞用于肝细胞癌的免疫细胞治疗
Asian Pac J Cancer Prev. 2019 Dec 1;20(12):3797-3803. doi: 10.31557/APJCP.2019.20.12.3797.
8
Interleukin-15 supports generation of highly potent clinical-grade natural killer cells in long-term cultures for targeting hematological malignancies.白细胞介素-15 在长期培养中支持生成高效的临床级自然杀伤细胞,用于靶向血液系统恶性肿瘤。
Exp Hematol. 2011 Sep;39(9):904-14. doi: 10.1016/j.exphem.2011.06.003. Epub 2011 Jun 13.
9
Artificial feeder cells expressing ligands for killer cell immunoglobulin-like receptors and CD94/NKG2A for expansion of functional primary natural killer cells with tolerance to self.表达杀伤细胞免疫球蛋白样受体和 CD94/NKG2A 配体的人工饲养细胞用于扩增具有自我耐受功能的功能性原代自然杀伤细胞。
Cytotherapy. 2020 Jul;22(7):354-368. doi: 10.1016/j.jcyt.2020.02.004. Epub 2020 May 23.
10
Establishment of an efficient ex vivo expansion strategy for human natural killer cells stimulated by defined cytokine cocktail and antibodies against natural killer cell activating receptors.建立一种有效的体外扩增策略,用于由特定细胞因子鸡尾酒和抗自然杀伤细胞激活受体抗体刺激的人类自然杀伤细胞。
Regen Ther. 2022 Jul 21;21:185-191. doi: 10.1016/j.reth.2022.07.001. eCollection 2022 Dec.

引用本文的文献

1
Building a Better Defense: Expanding and Improving Natural Killer Cells for Adoptive Cell Therapy.构建更好的防御:扩增和改善自然杀伤细胞用于过继性细胞治疗
Cells. 2024 Mar 5;13(5):451. doi: 10.3390/cells13050451.
2
Circulating natural killer cells and their association with breast cancer and its clinico-pathological characteristics.循环自然杀伤细胞及其与乳腺癌及其临床病理特征的关联。
Ecancermedicalscience. 2023 Jul 3;17:1567. doi: 10.3332/ecancer.2023.1567. eCollection 2023.
3
Temporal Expression of Transcription Factor Improves Natural Killer Cell Differentiation from Human Pluripotent Stem Cells.

本文引用的文献

1
Optimization of Human NK Cell Manufacturing: Fully Automated Separation, Improved Ex Vivo Expansion Using IL-21 with Autologous Feeder Cells, and Generation of Anti-CD123-CAR-Expressing Effector Cells.人自然杀伤细胞制备的优化:全自动分离,使用 IL-21 和自体饲养细胞进行体外扩增的改进,以及生成表达抗 CD123-CAR 的效应细胞。
Hum Gene Ther. 2017 Oct;28(10):897-913. doi: 10.1089/hum.2017.157. Epub 2017 Aug 15.
2
Ex vivo expanded natural killer cells from breast cancer patients and healthy donors are highly cytotoxic against breast cancer cell lines and patient-derived tumours.来自乳腺癌患者和健康供体的体外扩增自然杀伤细胞对乳腺癌细胞系和患者来源的肿瘤具有高度细胞毒性。
Breast Cancer Res. 2017 Jul 1;19(1):76. doi: 10.1186/s13058-017-0867-9.
3
转录因子的时间表达可改善人多能干细胞中自然杀伤细胞的分化。
ACS Synth Biol. 2022 Jun 17;11(6):2001-2008. doi: 10.1021/acssynbio.2c00017. Epub 2022 May 24.
4
Advances in NK cell production.自然杀伤细胞生产的进展。
Cell Mol Immunol. 2022 Apr;19(4):460-481. doi: 10.1038/s41423-021-00808-3. Epub 2022 Jan 5.
5
A Novel CAR Expressing NK Cell Targeting CD25 With the Prospect of Overcoming Immune Escape Mechanism in Cancers.一种表达靶向CD25的新型嵌合抗原受体自然杀伤细胞,有望克服癌症中的免疫逃逸机制。
Front Oncol. 2021 May 14;11:649710. doi: 10.3389/fonc.2021.649710. eCollection 2021.
6
Renaissance of armored immune effector cells, CAR-NK cells, brings the higher hope for successful cancer therapy.装甲免疫效应细胞,即 CAR-NK 细胞的复兴,为癌症治疗的成功带来了更高的希望。
Stem Cell Res Ther. 2021 Mar 22;12(1):200. doi: 10.1186/s13287-021-02251-7.
Silencing NKG2D ligand-targeting miRNAs enhances natural killer cell-mediated cytotoxicity in breast cancer.沉默靶向NKG2D配体的微小RNA可增强自然杀伤细胞介导的乳腺癌细胞毒性。
Cell Death Dis. 2017 Apr 6;8(4):e2740. doi: 10.1038/cddis.2017.158.
4
New Immunotherapy Strategies in Breast Cancer.乳腺癌的新型免疫治疗策略
Int J Environ Res Public Health. 2017 Jan 12;14(1):68. doi: 10.3390/ijerph14010068.
5
Highly efficient IL-21 and feeder cell-driven expansion of human NK cells with therapeutic activity in a xenograft mouse model of melanoma.在黑色素瘤异种移植小鼠模型中,高效的白细胞介素-21和饲养细胞驱动的具有治疗活性的人自然杀伤细胞的扩增。
Oncoimmunology. 2016 Aug 5;5(9):e1219007. doi: 10.1080/2162402X.2016.1219007. eCollection 2016.
6
Phase I Study of Random Healthy Donor-Derived Allogeneic Natural Killer Cell Therapy in Patients with Malignant Lymphoma or Advanced Solid Tumors.随机健康供体来源的同种异体自然杀伤细胞疗法治疗恶性淋巴瘤或晚期实体瘤患者的I期研究。
Cancer Immunol Res. 2016 Mar;4(3):215-24. doi: 10.1158/2326-6066.CIR-15-0118. Epub 2016 Jan 19.
7
Natural Killer Cell-Based Therapies Targeting Cancer: Possible Strategies to Gain and Sustain Anti-Tumor Activity.基于自然杀伤细胞的癌症治疗:获得并维持抗肿瘤活性的可能策略。
Front Immunol. 2015 Nov 30;6:605. doi: 10.3389/fimmu.2015.00605. eCollection 2015.
8
The Application of Natural Killer Cell Immunotherapy for the Treatment of Cancer.自然杀伤细胞免疫疗法在癌症治疗中的应用。
Front Immunol. 2015 Nov 17;6:578. doi: 10.3389/fimmu.2015.00578. eCollection 2015.
9
A Novel Method for Assessment of Natural Killer Cell Cytotoxicity Using Image Cytometry.一种使用图像细胞术评估自然杀伤细胞细胞毒性的新方法。
PLoS One. 2015 Oct 22;10(10):e0141074. doi: 10.1371/journal.pone.0141074. eCollection 2015.
10
"Adherent" versus Other Isolation Strategies for Expanding Purified, Potent, and Activated Human NK Cells for Cancer Immunotherapy.用于癌症免疫治疗的扩增纯化、强效且活化的人自然杀伤细胞的“贴壁”与其他分离策略
Biomed Res Int. 2015;2015:869547. doi: 10.1155/2015/869547. Epub 2015 Jun 16.